Systems modeling of metabolic dysregulation in neurodegenerative diseases. (October 2021)

• Record Type: Journal Article
• Authors: Baloni, Priyanka; Funk, Cory C.; Readhead, Ben; Price, Nathan D.
• Is Part Of: Current opinion in pharmacology. Volume 60(2021)
• Page Start: 59
• Page End: 65
• Publication Date: 2021-10
• Subjects: Neurodegenerative diseases, Metabolic modeling, Multiomics analysis, Network approaches; Pharmacology -- Periodicals; Pharmaceutical Preparations -- Periodicals; Drug Therapy -- Periodicals; Biopharmaceutics -- Periodicals; Pharmacologie -- Périodiques; Pharmacology; Periodicals; 615.105
• DOI: 10.1016/j.coph.2021.06.012
• Languages: English
• ISSNs: 1471-4892

Abstract

Abstract: Neurodegenerative diseases (NDDs) encompass a wide range of conditions that arise owing to progressive degeneration and the ultimate loss of nerve cells in the brain and peripheral nervous system. NDDs such as Alzheimer's, Parkinson's, and Huntington's diseases negatively impact both length and quality of life, due to lack of effective disease-modifying treatments. Herein, we review the use of genome-scale metabolic models, network-based approaches, and integration with multiomics data to identify key biological processes that characterize NDDs. We describe powerful systems biology approaches for modeling NDD pathophysiology by leveraging in silico models that are informed by patient-derived multiomics data. These approaches can enable mechanistic insights into NDD-specific metabolic dysregulations that can be leveraged to identify potential metabolic markers of disease and predisease states.